CSF3R and cyclic hematopoiesis: Most likely, intracellular molecular defects specific for disturbed granulopoiesis in CN patients (39) and not G-CSF therapy per se, is responsible for the acquisition of CSF3R mutations in some HSC clones and clonal overgrowth of these clones.